Philippe Rouanet is an expert in Surgery at Institut du Cancer de Montpellier (France). As of October 2026, ScienceLeadR ranks Philippe Rouanet in the top 1% of experts worldwide for Rectal Diseases, Intestinal Neoplasms and Gastrointestinal Neoplasms. Philippe Rouanet has authored 370 publications, the most recent in 2026, and is an investigator in 32 clinical trials, 6 of them ongoing. SLR score: 1,342 (community average: 125). How the SLR is computed.

LeadR Profile

Philippe Rouanet Institut du Cancer de Montpellier France
1 342 ScienceLeadR Reputation 1342
Network Map

Surgery

Subspecialties: Oncology - Gastroenterology - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1991 - 2026

Source: PubMed

University of Montpellier

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 370

Citations

Citations: 13 463 1st author: 41 Last author: 47 Unique author: 12


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Oncological impact of adjuvant chemotherapy after rectal cancer excision in the era of FOLFIRINOX-based TNT: A pooled post-hoc analysis of GRECCAR4-PRODIGE23.
PMID 42743888 — neoplasms, drug therapy, chemotherapy, adjuvant, neoadjuvant therapy, rectal neoplasms, therapeutics, chemotherapy
Eur J Cancer20260
Safety and Performance of the Colovac Anastomosis Protection Device. A Pooled Analysis of Prospective Studies Compared With Diverting Loop Ileostomy (SAFE-2025).
PMID 42681563 — ostomy, safety, neoplasms, rectal neoplasms, anastomotic leak, general surgery, ileostomy, prospective studies
Ann Surg20260
Indocyanine green-guided robotic-assisted mesorectal lymphadenectomy for high-risk T1 rectal carcinoma: Preliminary results of a prospective cohort study (IDEAL stage 2a).
PMID 42458874 — lymph nodes, lymph node excision, cohort studies, arteries, neoplasm metastasis, lymph, colorectal neoplasms, indocyanine green
Colorectal Dis20260
Risk factors associated with urinary tract infection within 4 days of male rectal cancer surgery in the era of enhanced recovery after surgery (ERAS) programs.
PMID 42246495 — urinary tract, neoplasms, recycling, urinary tract infections, rectal neoplasms, risk factors, enhanced recovery after surgery, general surgery, catheterization, infections
Acta Chir Belg20260
Navigating Pelvic Anatomy for Exenteration: A Clinical Guide for Radiologists.
PMID 42236291 — fibrosis, radiologists, radiology, anatomy
Br J Radiol20260

Clinical Studies 32

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 7 Study Chair: 6

By phase:

N/A 19
Phase 3 9
Phase 2 3
Phase 2/Phase 3 1

By status:

Completed 13
Recruiting 10
Terminated 4
Active not recruiting 3
Unknown 2

By type:

Interventional 28
Observational 4

By Monocentric/Multicentric:

monocentric 13
multicentric2to4 3
multicentric5to9 1
multicentricup10 15

Main Topics

Cohort/Consortium Investigators 2

Ongoing Clinical Trials

6 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Safety Efficacy of Ischemic Preconditioning by Embolization of the Inferior Mesenteric Artery in Surgery for Tumors of Lower and Middle Rectum
NCT06236633 — injections, pilot projects, telephone, pilots, fistula, safety, blood, absenteeism, hematoma, radiologists, neoplasms, mesenteric artery, superior, colon, arteries, rectum, radiology, mesenteric arteries, rectal neoplasms, research, ischemic preconditioning, punctures, mesenteric artery, inferior, ischemia, radiology, interventional, surgeons
N/ARecruiting2024
Interest of Early Erectile Rehabilitation With Sildenafil After Radiotherapy and Proctectomy for Rectal Cancer
NCT06123156 — radiotherapy, neoplasms, rehabilitation, sildenafil citrate, rectum, proctectomy, rectal neoplasms, blood platelets
Phase 3Recruiting2025
Trial Evaluating the Tailored Versus the Systematic Use of Defunctioning Stoma After Total Mesorectal Excision for Rectal Cancer (GRECCAR17)
NCT05233787 — quality of life, neoplasms, enema, sepsis, rectal neoplasms, anastomotic leak, ileostomy
N/ARecruiting2022
Study Evaluating the Tailored Management of Locally advanced Rectal Carcinoma
NCT04749108 — radiotherapy, intensity-modulated, radiotherapy, induction chemotherapy, radiologists, neoplasms, drug therapy, oxaliplatin, proctectomy, chemoradiotherapy, rectal neoplasms, morbidity, therapeutics, software, capecitabine, laparotomy, irinotecan, chemotherapy, carcinoma
Phase 2/Phase 3Recruiting2021
Peristomal Hernia Rate 5 Years After a Terminal Colostomy With the Parietex TCM Parietal Prosthesis Versus Without Mesh
NCT04282473 — hernia, epidemiology, colostomy
N/ARecruiting2022

LeadR Networks

Main global connection map